In this article for The Lancet, KFF’s Jennifer Kates and Lindsey Dawson, and five co-authors provide an overview of the coverage and financing landscape for HIV treatment and prevention in the U.S., discuss how the Affordable Care Act has changed the domestic health care system,… Read More »Insurance coverage and financing landscape for HIV treatment and prevention in the USA
Is the exaggerated reaction of many Crohn’s disease patients to baker’s, brewer’s, and nutritional yeast just a consequence of their inflamed leaky gut, or might the yeast be a contributing cause? “Baker’s Yeast in Crohn’s Disease—Can It Kill You?” is the inflammatory title (no pun… Read More »Does Nutritional Yeast Trigger Crohn’s Disease?
New KFF Analysis Finds 40 Out of 46 PEPFAR Countries Have Met At Least One HIV Target, Though No Countries Have Met All Progress Measures
A new KFF analysis finds that across 46 PEPFAR countries and among six different indicators of progress, the majority (40) has met at least one target, 17 countries have met at least half of the targets, and one country has met five targets. No country… Read More »New KFF Analysis Finds 40 Out of 46 PEPFAR Countries Have Met At Least One HIV Target, Though No Countries Have Met All Progress Measures
This explainer provides an overview of the federal “Ending the HIV Epidemic” initiative and explores issues that might mitigate or facilitate its success.
In the final hours of the previous Administration’s time in office, the Center for Medicare & Medicaid Innovation (the Innovation Center) (CMMI) announced new changes for CY 2022 to an existing five-year Part D Payment Modernization Model. This model would provide “formulary flexibility” by exempting… Read More »Action needed to preserve the six protected classes
Ted Howard started taking Truvada a few years ago because he wanted to protect himself against HIV, the virus that causes AIDS. But the daily pill was so pricey he was seriously thinking about giving it up. Under his insurance plan, the former flight attendant… Read More »Many Health Plans Now Must Cover Full Cost of Expensive HIV Prevention Drugs
This survey of Ryan White-funded providers examines the significant challenges posed by the COVID-19 pandemic on the people with HIV and the systems that serve them.
This brief outlines the potential health policy actions that President Biden could take using executive authority, based on campaign pledges, and actions that would reverse or modify regulations or guidance issued by the Trump Administration.
This tracker provides regularly updated information on U.S. government funding for global health. It includes historical trends and tracks funding levels throughout the appropriations process. Data can be customized by fiscal year, sector, and U.S. agency.
In Ethiopia, health clinics for teenagers once supported by U.S. foreign aid closed down. In Kenya, a decades-long effort to integrate HIV testing and family planning unraveled. And in Nepal, intrepid government workers who once traversed the Himalayas to spread information about reproductive health were… Read More »Trump’s Anti-Abortion Zeal Shook Fragile Health Systems Around the World
This fact sheet provides an overview of the Ryan White Program, the largest HIV-specific federal grant program in the United States.
Study finds biopharmaceutical innovation is responsible for 35% of the increase in life expectancy from 1990 to 2015
Medicines are responsible for more than a third of the improvement in life expectancy from 1990 to 2015, according to a recent study published in Health Affairs. This underscores the crucial role of biopharmaceutical innovation, as life expectancy increased 3.3 years during that time period.
Proposed change to Medicaid line extension definition ignores importance of critical improvements in treatments
In comments recently submitted to the administration, PhRMA raised concerns with a number of changes included in the Centers for Medicare & Medicaid Services (CMS) Medicaid proposed rule. Today, we’re diving deeper into CMS’s proposal to vastly expand the types of medicines that would fall… Read More »Proposed change to Medicaid line extension definition ignores importance of critical improvements in treatments
This side-by-side comparison examines President Trump’s record and former Vice President Biden’s positions across a wide range of key health issues, including the response to the pandemic, the Affordable Care Act marketplace, Medicaid, Medicare, drug prices, reproductive health, mental health and opioids, immigration and health… Read More »Health Care and the 2020 Presidential Election
Commercial health plans have increased patients’ out-of-pocket costs by over 50% in some therapeutic areas
According to a recent IQVIA analysis, commercial health plans have increased patients’ average out-of-pocket costs for brand medicines by over 50% in some therapeutic areas since 2015. Notably, of the seven therapeutic areas that IQVIA analyzed, including anticoagulants, asthma/COPD, depression, diabetes, HIV, multiple sclerosis and… Read More »Commercial health plans have increased patients’ out-of-pocket costs by over 50% in some therapeutic areas
This tracker provides up-to-date data on federal Ending the HIV Epidemic (EHE( funding, including an overview of funding mechanisms by year, agency, grant mechanism, and jurisdiction. It will be updated over time.
Earlier this month, the International AIDS Conference – the world’s largest conference on HIV and AIDS – took place on a virtual stage. Over five days, the conference showcased the latest research and analysis by leaders in the HIV sector. On Friday, July 24, 9:00 a.m. -10:00 a.m., the CSIS Global Health… Read More »Online Event: Highlights from the Virtual AIDS 2020 Conference
This updated fact sheet provides the latest data on the global HIV/AIDS epidemic, including impact by region, treatment and prevention efforts, and an overview of the U.S. and global responses to the epidemic.
Health insurance coverage and access to care improve health outcomes, including viral suppression, for people with HIV in the United States. Prior research has demonstrated that implementation of the Affordable Care Act (ACA) in 2014 increased coverage among people with HIV and that certain forms… Read More »Insurance Coverage and Viral Suppression Among People with HIV in the United States, 2015-2018
Quantifying PEPFAR’s Role for Women and Girls: Analysis of Monitoring, Evaluation, and Reporting Indicator Data, 2016-2019
Women and girls represent more than half of all people living with HIV worldwide, and HIV is the leading cause of death among women aged 15-49. This analysis sought to quantify PEPFAR’s role for women and girls in key program areas, analyzing data over time… Read More »Quantifying PEPFAR’s Role for Women and Girls: Analysis of Monitoring, Evaluation, and Reporting Indicator Data, 2016-2019
KFF/UNAIDS Analysis Finds Donor Governments Spent US$7.8 Billion for HIV in 2019, Down Almost $200 Million From the Previous Year
Half of the 14 donor governments analyzed in the study decreased their spending on global HIV efforts from 2018 to 2019; six increased; and one held steady. Donor government funding supports HIV care and treatment, prevention and other services in low- and middle-income countries.
This report from KFF and The Joint United Nations Programme on HIV/AIDS (UNAIDS) finds donor government disbursements to combat HIV in low- and middle-income countries totaled US$7.8 billion in 2019, a reduction from the US$8 Billion in 2018 and nearly the same as the funding… Read More »Donor Government Funding for HIV in Low- and Middle-Income Countries in 2019